Evidence map›Paper›PMID 42668330›Full record

ArticleJournal of cancer survivorship : research and practice2026

Patterns of sexual dysfunction among breast cancer survivors five years after diagnosis: a latent class analysis of the French VICAN5 study.

Eqbal Radwan, Lorène Seguin, Magali Provansal, Julien Mancini, Anne-Déborah Bouhnik

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eqbal RadwanAix-Marseille Univ, Inserm, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, Équipe Calipso labélisée Ligue 2024, ISSPAM, Institut Paoli-Calmettes, 232 Bd Ste Marguerite, IPC5, BP156, Marseille, 13273 cedex 9, France.
Lorène SeguinInstitut Paoli-Calmettes, Département d'Oncologie Médicale, Marseille, France.
Magali ProvansalInstitut Paoli-Calmettes, Département d'Oncologie Médicale, Marseille, France.
Julien ManciniAix-Marseille Univ, Inserm, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, Équipe Calipso labélisée Ligue 2024, ISSPAM, Institut Paoli-Calmettes, 232 Bd Ste Marguerite, IPC5, BP156, Marseille, 13273 cedex 9, France. julien.mancini@univ-amu.fr.
Anne-Déborah BouhnikAix-Marseille Univ, Inserm, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de l'Information Médicale, Équipe Calipso labélisée Ligue 2024, ISSPAM, Institut Paoli-Calmettes, 232 Bd Ste Marguerite, IPC5, BP156, Marseille, 13273 cedex 9, France.

Funding

French National Institute of Cancer (INCa) 05-2011
6 · The paper itself

Abstract

purposeSexual health concerns are highly prevalent among breast cancer survivors. Sexual dysfunction can occur from various causes, including the cancer itself, treatment side effects, and psychological distress. Therefore, this study aimed to identify distinct patterns of sexual dysfunction among women in remission from breast cancer 5 years after diagnosis using latent class analysis (LCA) and to examine factors associated with higher sexual dysfunction classes.

methodsWe conducted a cross-sectional secondary analysis of data from 356 women participating in the French nationwide VICAN5 survey 5 years after breast cancer diagnosis. Sexual dysfunction was assessed using five selected items from the Relationship and Sexuality Scale (RSS), and LCA was applied to these indicators to identify distinct dysfunction patterns. Ordinal logistic regression was used to examine factors associated with higher sexual dysfunction classes.

resultsA three-class model best fit the data, identifying no/low (n = 124, 34.8%), moderate (n = 133, 37.4%), and high (n = 99, 27.8%) sexual dysfunction classes. Older age at diagnosis (>50 years) (aOR, 2.30; 95% CI, 1.34-3.97; p = 0.003), frequent alcohol consumption (aOR, 2.00; 95% CI, 1.05-3.84; p = 0.036), radiotherapy (aOR, 2.36; 95% CI, 1.21-4.61; p = 0.012), current adjuvant endocrine therapy use (aOR, 1.87; 95% CI, 1.14-3.06; p = 0.013), frequent excessive sweating (aOR, 1.67; 95% CI, 1.01-2.77; p = 0.047), frequent paresthesia in the breast/arm (aOR, 1.78; 95% CI, 1.07-2.95; p = 0.026), hypnotic use (aOR, 1.66; 95% CI, 1.09-2.53; p = 0.018), and feeling less sexually attractive (aOR, 4.72; 95% CI, 3.01-7.41; p < 0.001) were associated with higher odds of being in a higher sexual dysfunction class.

conclusionsSexual dysfunction remained common 5 years after breast cancer diagnosis, with more than one-quarter of survivors having high sexual dysfunction. These results suggest that the assessment of sexual health should be incorporated into survivorship care for breast cancer, especially in women experiencing issues with body image and persistent treatment symptoms. IMPLICATIONS FOR CANCER SURVIVORS: Sexual health should be integrated into survivorship care, including oncosexual consultations, psychosexual support for body image concerns, and management of persistent treatment-related symptoms.

Indexed as

Adjuvant endocrine therapy (AET)Breast cancer survivorsExcessive sweatingLatent class analysisParesthesiaSexual dysfunction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.